Environmental Health Division, Minnesota Department of Health, St Paul, Minnesota.
J Public Health Manag Pract. 2019 Jan/Feb;25 Suppl 1, Lead Poisoning Prevention:S44-S50. doi: 10.1097/PHH.0000000000000879.
A typical strategy for identifying children with elevated blood lead levels (BLL) is to use a test on a capillary sample as a screening tool and then perform a confirmatory test on a venous sample following an elevated capillary screen. However, tests on capillary samples are prone to false-positive results, which affect surveillance estimates of the prevalence of elevated BLL.
We sought to measure the prevalence and risk of false-positive results in elevated tests on capillary samples based on various potential predictors.
DESIGN, SETTING, PARTICIPANTS, AND MAIN OUTCOME MEASURES: We analyzed blood lead results for children aged 0 to 6 years tested during 2011 to 2017 in Minnesota. A false positive was defined as a test on a capillary sample of at least 5 μg/dL, followed by a test result on a venous sample less than 5 μg/dL within 90 days. Binomial regression was used to estimate the probability of false-positive results dependent on the initial test result and the time between initial and confirmatory tests.
Results from 3898 children were included in analyses. Of these, 2330 (60%) had confirmatory results below 5 μg/dL and were classified as false positives. The proportion of false positives varied with time between tests, dependent on the initial result. Extrapolating the model to zero days between tests, without time for any change in the child's true BLL, we predicted 55% false positives in this study group (95% confidence interval: 53%-57%).
Caution is warranted when interpreting elevated tests on capillary samples without confirmatory tests on venous samples. Providers should be encouraged to follow up all elevated capillary screens with confirmatory tests on venous samples.
识别血铅水平升高(BLL)儿童的典型策略是使用毛细血管样本检测作为筛查工具,然后在毛细血管筛查结果升高后,对静脉样本进行确认性检测。然而,毛细血管样本检测容易出现假阳性结果,这会影响到对升高的 BLL 患病率的监测估计。
我们试图根据各种潜在预测因素,测量毛细血管样本升高检测中的假阳性率和风险。
设计、设置、参与者和主要结局指标:我们分析了 2011 年至 2017 年期间在明尼苏达州接受检测的 0 至 6 岁儿童的血铅结果。假阳性定义为毛细血管样本检测结果至少为 5μg/dL,随后在 90 天内静脉样本检测结果小于 5μg/dL。二项式回归用于估计初始检测结果和初始与确认检测之间的时间依赖于假阳性结果的概率。
3898 名儿童的结果被纳入分析。其中,2330 名(60%)的确认结果低于 5μg/dL,被归类为假阳性。假阳性的比例随检测之间的时间而变化,取决于初始结果。将模型外推至无检测间隔(即,没有时间让儿童的真实 BLL 发生任何变化),我们预测该研究组中假阳性率为 55%(95%置信区间:53%-57%)。
在没有静脉样本确认性检测的情况下,对毛细血管样本中升高的检测结果进行解释时应谨慎。应鼓励提供者对所有升高的毛细血管筛查进行静脉样本确认性检测。